Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
&NA; Albendazole (ABZ) is a microtubule‐targeting anthelmintic that acts against a variety of human cancer cells, but the dependence of its cytotoxicity on non‐mitotic effect remains elusive. Thus, we aimed to explore the mechanistic pathway underlying the cytotoxicity of ABZ in human leukemia U937 cells. ABZ‐induced apoptosis of U937 cells was characterized by mitochondrial ROS generation, p38 MAPK activation, TNF‐&agr; upregulation and activation of the death receptor‐mediated pathway. Meanwhile, ABZ induced tubulin depolymerization and G2/M cell cycle arrest. ABZ‐induced SIRT3 degradation elicited ROS‐mediated p38 MAPK activation, leading to pyruvate kinase M2‐mediated tristetraprolin (TTP) degradation. Inhibition of TTP‐mediated TNF‐&agr; mRNA decay elicited TNF‐&agr; upregulation in ABZ‐treated cells. Either the overexpression of SIRT3 or abolishment of ROS/p38 MAPK activation suppressed TNF‐&agr; upregulation and rescued the viability of ABZ‐treated cells. In contrast to the inhibition of ROS/p38 MAPK pathway, SIRT3 overexpression attenuated tubulin depolymerization and G2/M arrest in ABZ‐treated cells. Treatment with a SIRT3 inhibitor induced TNF‐&agr; upregulation and cell death without the induction of G2/M arrest in U937 cells. Taken together, our data indicate that ABZ‐induced SIRT3 downregulation promotes its microtubule‐destabilizing effect, and that the non‐mitotic effect of ABZ largely triggers apoptosis of U937 cells via SIRT3/ROS/p38 MAPK/TTP axis‐mediated TNF‐&agr; upregulation. Notably, the same pathway is involved in the ABZ‐induced death of HL‐60 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-activated protein kinases in apoptosis regulation
Wada, T., & Penninger, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207556 · Cited by 1,432
Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?
Son, Y., Cheong, Y.-K., Kim, N.-H., Chung, H.-T., Kang, D. G., & Pae, H.-O. (2011) · Journal of Signal Transduction · doi:10.1155/2011/792639 · Cited by 1,219
Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS
Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K., Zhao, S., & Xiong, Y. (2011) · The EMBO Reports · doi:10.1038/embor.2011.65 · Cited by 572
Self-citationLacey, E. (1988) · International Journal for Parasitology · doi:10.1016/0020-7519(88)90175-0 · Cited by 560
Modes of action of anthelmintic drugs
Martin, R. J. (1997) · The Veterinary Journal · doi:10.1016/s1090-0233(05)80005-x · Cited by 538
Mitosis is not a key target of microtubule agents in patient tumors
Komlodi-Pasztor, E., Sackett, D., Wilkerson, J., & Fojo, T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.228 · Cited by 314
In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole
Pourgholami, M. H., Woon, L., Almajd, R., Akhter, J., Bowery, P., & Morris, D. L. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00382-2 · Cited by 139
Albendazole as a promising molecule for tumor control
Castro, L. S. E. P. W., Kviecinski, M. R., Ourique, F., Parisotto, E. B., Grinevicius, V. M. A. S., Correia, J. F. G., Wilhelm Filho, D., & Pedrosa, R. C. (2016) · Redox Biology · doi:10.1016/j.redox.2016.09.013 · Cited by 81
Pourgholami, M. H., Szwajcer, M., Chin, M., Liauw, W., Seef, J., Galettis, P., Morris, D. L., & Links, M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1157-8 · Cited by 69
Albendazole sensitizes cancer cells to ionizing radiation
Patel, K., Doudican, N. A., Schiff, P. B., & Orlow, S. J. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-160 · Cited by 66
Cited by
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Zhang, J., Xiang, H., Liu, J., Chen, Y., He, R.-R., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.45922 · Cited by 503
Self-citationThe Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs
Son, D.-S., Lee, E.-S., & Adunyah, S. E. (2020) · Immune Network · doi:10.4110/in.2020.20.e29 · Cited by 130
Nath, J., Paul, R., Ghosh, S. K., Paul, J., Singha, B., & Debnath, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118189 · Cited by 71
Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
Song, B., Park, E. Y., Kim, K. J., & Ki, S. H. (2022) · Cancers · doi:10.3390/cancers14194601 · Cited by 55
Antitumor Effect of Albendazole on Cutaneous Squamous Cell Carcinoma (SCC) Cells
Zhang, Q.-L., Lian, D.-D., Zhu, M. J., Li, X. M., Lee, J. K., Yoon, T.-J., Lee, J.-H., Jiang, R.-H., & Kim, C. D. (2019) · BioMed Research International · doi:10.1155/2019/3689517 · Cited by 26
Metadata
- Authors
- Wang, L.-J., Lee, Y.-C., Huang, C.-H., Shi, Y.-J., Chen, Y.-J., Pei, S.-N., Chou, Y.-W., & Chang, L.-S.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 162
- Pages
- 154-168
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2899547828
- Cited by
- 50
- References
- 10
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation. https://app.cochat.ai/papers/10.1016/j.bcp.2018.11.003
- The paper
- Wang, L.-J., Lee, Y.-C., Huang, C.-H., Shi, Y.-J., Chen, Y.-J., Pei, S.-N., Chou, Y.-W., & Chang, L.-S. (2019). Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2018.11.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.